|
    NRBO U.S.: Nasdaq

    NeuroBo Pharmaceuticals Inc.

    Watchlist
    NEW
    Set a price target alert
    NRBOUS
    Premarket
    Last Updated: Feb 2, 2024 4:28 a.m. EST Delayed quote

    $ 5.20

    -0.27 -4.94%
    Before Hours Volume: 14.84K
    Close Chg Chg %
    $5.47 2.20 67.28%
    Advanced Charting
    Volume: 68.52M 65 Day Avg: 1.09M
    6,303% vs Avg
    3.96 Day Range 6.06
    2.89 52 Week Range 7.60

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    NRBO Overview

    Key Data

    • Open $3.96
    • Day Range 3.96 - 6.06
    • 52 Week Range 2.89 - 7.60
    • Market Cap $15.86M
    • Shares Outstanding 4.85M
    • Public Float 3.2M
    • Beta 0.65
    • Rev. per Employee N/A
    • P/E Ratio N/A
    • EPS -$2.88
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 19.14K 01/12/24
    • % of Float Shorted 0.60%
    • Average Volume 1.09M

    Performance

    5 Day
    • 78.18%
    1 Month
    • 40.98%
    3 Month
    • 62.80%
    YTD
    • 47.97%
    1 Year
    • -15.79%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    Dow Jumps 250 Points; Honeywell Issues Weak Forecast

    on Benzinga.com

    Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    on Benzinga.com

    12 Health Care Stocks Moving In Thursday's Intraday Session

    on Benzinga.com

    Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations

    on Benzinga.com

    Why Obesity-Drug Maker NeuroBo Stock Is Trading Higher

    on Benzinga.com

    Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000

    on Benzinga.com

    What's Going On With Clinical-Stage Biotech Firm NeuroBo Shares Today?

    on Benzinga.com

    12 Health Care Stocks Moving In Tuesday's After-Market Session

    on Benzinga.com

    The Zacks Analyst Blog Highlights Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals

    on Zacks.com

    4 Undervalued Medical Stocks to Buy Amid High Market Volatility

    on Zacks.com

    Want to Shrug Off Volatility? Buy 3 Medical Growth Stocks

    on Zacks.com

    12 Health Care Stocks Moving In Friday's After-Market Session

    on Benzinga.com

    12 Health Care Stocks Moving In Monday's Intraday Session

    on Benzinga.com

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    on Benzinga.com

    Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    on Benzinga.com

    NeuroBo Pharma Says Its Weight Loss Candidate Outperforms Major Competitors in Preclinical Obesity Study

    on Benzinga.com

    Here's Why NeuroBo Pharmaceuticals, Inc. (NRBO) Could be Great Choice for a Bottom Fisher

    on Zacks.com

    Stocks That Hit 52-Week Lows On Monday

    on Benzinga.com

    Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket

    on Benzinga.com

    Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket

    on Benzinga.com